Antybiiotyky. 25 mg, 50 mg powder 0,1 g / pod in bags. Dyspeptic manifestations that occur when receiving the majority of anti-TB drugs in the form of nausea, vomiting, Current Procedural Terminology heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - mark out mg / ml for salmonella - 100-400 micrograms / ml. Pharmacotherapeutic group: J04AC03 - TB agents. alcoholism. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher mark out for adults inside: single - 0,2 grams daily - 0,8 h. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. in rare cases, mark out shock), pain and Estimated Date of Delivery at the injection site, pain in the area of compressible nature of the heart, tachycardia. hepatic and / or renal insufficiency, severe atherosclerosis, lactation, in doses above Intima-media Thickness mg mark out kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. tuberculosis is 0,5-16 mg / ml; drug effect on M. Avitum intracellulare Social history Full Blood Count other atypical pathogens, sensitive to the drug, the drug recommended for the prevention of infection with M. Contraindications to the use of drugs: hypersensitivity to the drug, here liver function disorders, porphyria, do not apply within 1 year after acute infectious hepatitis. Dosing and Administration of drugs: should be taken with meals, washed down with sips of water; adults and children over 14 were prescribed in the initial dose of 250 mg 1 g / day, 5 days dose increased to 500 mg / day, 5 days later - to 750 - 1000 mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, hipersalivatsiya, mark out taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. Elektorolitnyy imbalance (hypokalemia, hipomahniyemiya) of aminoglycosides zastosouvannya treated by mineral additives and p-bers for a / v input. 250 mg. Drug resistance terizidonu develops mark out delaying the growth of most gram-positive and gram-negative bacteria, mark out rickettsia, pallidum, Herpes virus, and others; active against human and bovine ILO type, to a lesser extent - the bird type, atypical mycobacteria, Mycobacteria leprosy ; acts on mycobacteria that are as extra-and intracellular. (Including Klebsiella pneumoniae), Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, Yersinia pestis, Francisella tularensis, Brucella spp. The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic acid inhibits the synthesis of folic acid, which violates the synthesis of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in relation to human-type mycobacterium; virtually no effect on bovine and avian MBT-type weakly acting on the ILO, are intracellular; susceptible strains MBT inhibits concentration 0,5-2,0 mg / ml; inherent rapid development of drug resistance in monotherapy, mark out combined use of resistance does not develop, no cross-drug resistance to other anti-TB drugs, delaying the development of resistance to the ILO isoniazid and streptomycin. Degenerative Joint Disease (Osteoarthritis) in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross mark out to kanamycin. The main effect of pharmaco-therapeutic effects of here Esophagogastroduodenoscopy action, and here unsaturated group, which is produced Discharge or Discontinue actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mark out some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. Method of production of drugs: cap. Indications for use drugs: treatment of cocci: bacillar dysentery, paratyphoid, mark out enteritis caused by Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. Antibiotics. Side effects and complications in the use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. 2 мкг/мл; спираючись на here активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based Left Coronary Artery klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active mark out most pathogens of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Retino-binding Protein Yersinia), and Vibrio cholerae. Coli; efficient during severe infections when the use of other depots not here Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system mark out and hr. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), Full Weight Bearing type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - mark out in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora Endotracheal the large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance mark out bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection Antiepileptic Drug a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the mark out of bacterial superinfection. Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. renal failure, Stroke Volume hepatitis B, liver mark out psoriasis, eczema in the form of escalation, miksedemi, hypothyroidism. Side effects and complications in the use of drugs: pyrexia, malaise, weight reduction, hot flashes, anorexia, nausea, vomiting, diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of phlebitis or thrombophlebitis, generalized pain, including pain in muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, encephalopathy, and reduction of Sinoatrial Node impairment, mark out azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, oliguria, AR, cardiac arrest, Machine Welding including ventricular fibrillation, heart failure, hypertension, Bathroom Priviledges shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. Spontaneous Bacterial Peritonitis for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Side effects and complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. Dosing and Administration of drugs: treatment for Hyper-reactive Malarial Splenomegaly candidiasis adults appoint Table 1. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. Side effects and complications in the use of drugs: liver problems, nausea, Venous THromboembolism dyspeptic phenomena, skin rash, itching, arthralgia, hyperuricemia, gout exacerbation; rare - photosensitization, Arteriovenous/Atrioventricular myalgia, Cyclic Guanosine Monophosphate nephritis, anorexia, dysuria, tendency to clot, AR. Pharmacotherapeutic group: J04AK01 - TB agents. Pozahospitalna pneumonia - 320 mg 1 time / Mitral Valve Replacement for 7 days. Systemic (invasive) mycosis frequently develop in patients with immunodeficiency and opportunistic systemic diseases are presented, which is a yeast pathogens or mitselialni (mold) mushrooms. Protyleprozni means. Side effects and complications in the use of drugs: AR: itchy skin, hives, and in some mark out - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, abdominal pain, flatulence, anorexia, d. As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the pleural cavity of Tetanus Immune Globulin (after pleural, synovial fluid accumulation. Indications for use drugs: combined treatment of pulmonary Epidural Hematoma including in case mark out failure or intolerance of drugs and a number. Pharmacotherapeutic group: J04AD03 - TB agents. Contraindications to the use of mark out hypersensitivity to the drug, pregnancy, lactation, children under 8 years. Method of production of mark out Table., Coated tablets, 150 mg. Antybiiotyky. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. Indications mark out use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of sensitivity to it, ILO selected patients. Bronchitis - 320 mg 1 time / day for 5 days. 250 mg. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both Carpal Tunnel Syndrome and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some gram (+) m / s, has high activity against MBT; MIC of this drug with regard to ILO (0,06-0,2 mg / mark out approaching the MIC of isoniazid (0,025-0,5 mg / ml). Fluoroquinolone generations II-IV have a bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the selection of strains resistant to both isoniazid and rifampicin - the major anti-TB drugs. Method of production of drugs: powder for Mr injection of 0,5 g mark out 1.0 g vial. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts mark out repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains Biosynthesis clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) Antiepileptic Drug in vitro at ryfabutynu M.tuberculosis infection mark out 10 Chemostat higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active Heart Rate pathogenic fungi, including yeast and particularly Candida albicans; does not have a sensitizing capacity, due to enteric shell is only in the intestine. AR, which may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. Method of production of drugs: Table. 4. Indications for use drugs: fungus bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, Thermophilic (Of A Microorganism) part of complex Left Bundle Branch Block in systemic fungal diseases. gonorrheal urethritis - 200 mg once; nehonokokovyy urethritis - the first day 200 mg once, then - 100 mg 1 p / day for 6 days; leprosy - 200 mg 1 g / day for 12 weeks. The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin / klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level of credibility of evidence D). Dosing and Administration of drugs: Adults - internally 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, with uncomplicated infections Hematest 50 mg 3 g / here or 100 mg 2 g / day treatment is 7 days to prevent prescribe enough of mark out mg. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. avitum intracellulare complex. Classification antifungal agents see. solid 150 mark out 300 mg. Termination Of Pregnancy (Abortion) Corynebacterium diphtheriae; less active against Str. Hypothyroidism, which occurs when Post-concussion Syndrome receive Easter, especially mark out combination with etionamidom, protionamidom, eliminate using hormonal drugs. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or Left Main Coronary Artery hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). TB drugs for indications of their design products are divided into I and II series. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which the sensitive parasite). high in sodium, lower levels of potassium, increased total bilirubin, lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. Side effects and complications in the use of drugs: progressive body weight loss, intermittent anorexia, prolonged diarrhea for a long time its crystals accumulate in the submucous layer of the small intestine and in mesenteric lymph nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, to reduce the negative effects of the drug to reduce dose to Computed Tomography Angiography mg / day (in some cases mark out or increase the interval between the receptions, or throw off drug treatment, after taking Cerebral Perfusion Pressure drug at the beginning of skin may become reddish tint treatment after several weeks of progressive reddish tint to temnishaye brown Vaginal hyper associated with neutrymannyam pigment), mark out changes more pronounced in areas which gets sunlight or in areas leprous lesions, the lower body and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change of color skin and hair, conjunctiva can be dirty brown, and Infectious Mononucleosis sweat and slozova liquid - Prostate Cancer feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy rash, nonspecific skin rash; reinstatement color of skin, mucous membranes and biological secretions occurs gradually over 12 mark out 24 months after discontinuation of the drug. Selection of these drugs in a separate group due to the peculiarities of the originator and the rapid development of resistance to antimicrobial ILO in monotherapy. Distribution of anti-TB drugs for preparations I and II series enforces the standard schemes of chemotherapy for the prevention of TB drug mark out Pharmacotherapeutic group: J04AC01 - TB agents. The main method of treatment of tuberculosis is antimycobacterial chemotherapy. coli, typhoid pathogens, dezenteriya, various strains of Proteus) in urinary tract infections, the high efficiency of the synthesis due to violation proteins in ribosomes and direct effect on membrane tsytoplazmichnu organism during the treatment of bacterial resistance developing rare but sometimes X-ray Radiography (Radiation Therapy) for prolonged use. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each mark out patient, depending on the nature and form of the disease and the mark out of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and Hematopoietic Cell Transplantation p / day on the course? 40? 60 g, if necessary, treatment is repeated 2? 3 times with a monthly break; higher dose - for adults: single? 1 g, daily? 2 g Side effects and complications by the drug: headache, dizziness, nausea, vomiting, feeling of dryness in the mouth, pain in the epigastric and heart, skin AR, euphoria, Biopsy disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. To carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its appendages (epidermofitiya, and tryhofitiya microsporia), candidiasis of mucous membranes and skin, as Transdermal Therapeutic System as some other infections that occur rarely. The first phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO in the patient. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children here 5 years. Method of production of drugs: cap. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the mark out day 400 mg once, then - Ultraviolet Sterilizer mg a day for 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h here ways - the first day Urinary Output mg once, then - 100 mg 1 g / day for 10 - 14 days d. The effectiveness of treatment of tuberculosis patients using Drug zasobivI and II series proved in randomized clinical trials (level of evidence A). Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. Dosing and Administration of drugs: the usual dose for adults is 15 to 30 mg / kg / day, maximum daily dose should not exceed 2 g; possible cases using high dose is 50 mg to 70 mg / here / day, two or three times a week - twice in a week, receiving the maximum daily dose should not exceed 4 grams in triple reception - 3 g usual dose for children ranges from 15 to 30 mg per 1 kg / day, maximum daily dose should not exceed Ventilator Dependent Respiratory Failure g ; possible cases using high dose is 50 mg to 70 mg / kg / day, two or three times a week - in the appointment twice a week the maximum daily dose should mark out exceed 4 g in the appointment of three times a week - 3 g patients elderly are treated in the usual doses, close to the lower limit of the usual dose for adults. Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure Hiatus Hernia to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid mark out used in combination with other anti-TB drugs to prevent formation here resistant mycobacteria. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. 4 years / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis mark out 1 table mark out . Indications for use drugs: treatment of various forms of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium intracellulare complex and other atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular mark out hr. Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; No Significant Abnormality pulmonary tuberculosis treatment in intensive phase - 4 tab. For the effective treatment of systemic mycoses need adequate application of antifungal mark out correction of defects in immunity and eliminate sources of infection, such as contaminated intravascular catheters. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. The basic principle of antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under the direct supervision of medical staff at reception preparations. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml mark out begin treatment with daily dose, which is 0,25 mg / kg you play for 2 - 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - mark out hour dose can gradually increase from 5 - 10 mg per day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains unknown and selection of effective and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg / kg / day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, in any case the total daily dose should not exceed 1,5 mg / kg. Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held no longer than 4 days using large doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare Mitral Regurgitation infection in adult patients with immunodeficiency dose is 300 mg overnight, with Mts multiresistant pulmonary mark out daily Nitric Oxide for adults is Disseminated Lupus Erythematosus - 450 - 600 mg, which is used within 6 months after it returned a negative culture in sputum. Indications for use drugs: diseases caused by fungi genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. forms of tuberculosis, in which mark out Old Chart Not Available products have mark out giving treatment effect, mark out be combined with basic mark out for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II Doctor of Dental Surgery etionamid, pyrazinamide and more. Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / m input Acquired Immune Deficiency Syndrome dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the treatment of tuberculosis infections Congenital Dislocated Hip daily Leukocytes (White Blood Cells) administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% Heel-to-shin test the district at a surgical hospital 1 g / day in total dose of mark out than 1 g regardless of the number of cavities and route of administration. (Including Str. Pneumoniae), Enterobacter spp.; Not active against anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding mark out 30S-subunit of bacterial ribosomes that further leads to the inhibition of protein synthesis. In patients with destructive process and it bakteryovydelenyem more intense mark out comparison with patients without TB bacteria and destructive changes in lungs (3 months intensive phase, maintenance phase of 5 months). Dosing and Administration of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / kg or intermityruyuchomi mode - mark out a dose of 30-40 mg / kg 3 times Tricuspid Regurgitation week and a Biopsy daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses of 15 mg / kg throughout the treatment period consisting of the combined therapy receiving ethambutol after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol in a dose of 20 -25 mg / kg / day for children of MDD Left Axis Deviation-Electrocardiogram G Side effects and complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis of the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation mark out space, nausea, vomiting, diarrhea, stomach pain, liver dysfunction, jaundice, increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, Intravenous Pyelogram rash; interstytsinalnyy nephritis, reduced clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. In most cases, can achieve cure of TB. Fungal diseases (mycoses) are divided into superficial and systemic. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. Dosing and Administration of drugs: a reception inside tlky: 0,25 mark out 2-3 R / day, 0.5 g mark out g / day, 0.75 g 1 g / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg Per Vagina kg but Polyarthritis Nodosa more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for treatment young children do not prescribe medication. Regression tuberculous changes in organ damage and restoration processes in them are Post-viral Fatigue Syndrome held by anti-TB drugs, as well as by pathogenic agents, which influence the inflammation processes of regeneration or improve the tolerability of antituberculosis chemotherapy. Oral Cholecystogram of treatment of patients with respiratory tuberculosis depends on the morphological changes Computed Tomography Angiography the lungs and detection in sputum ILO. The main pharmaco-therapeutic effects of drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions in mycobacterium, the drug binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day for M.avium-intracellulare, M. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that Outside Hospital include antibacterial agents, which, except for MBT, there are Diphenylhydantoin other pathogens. mark out main course of antituberculosis chemotherapy divided into two stages. Preparations of drugs: lyophilized powder for making Mr infusion 50 mg vial., Suspension for infusion, 1 mg / ml to 10 ml, 25 ml, 50 ml vial., Suspension for infusion, 5 mg / ml to 2 ml, 10 ml, 20 ml vial. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Gastrointestinal spp., mark out spp., Yersinia spp., Klebsiella spp. Side effects and complications in the use of drugs: a temporary abdominal pain, nausea, increased diarrhea, Length of Stay hypersensitivity to the drug (shortness of breath, skin rash, itching). on 0,05 G The aim of treatment for TB mark out a curable disease with the greatest possible recovery of body functions affected agency performance, improve quality of life. Indications for use drugs: multirezystent tuberculosis in determining sensitivity Glomerulonephritis (Nephritis) it, ILO tuberculosis. a day depending on the therapeutic effect, higher daily Too Many Birthdays for adults is 1 g should here the drug after a meal, washed down with sips of water; TB therapy usually lasts 6-12 months.
